| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Nausea | FAERS: 3 | US FAERS | |
| 2 | Prothrombin time ratio decreased | FAERS: 3 | US FAERS | |
| 3 | Ascites | FAERS: 2 | US FAERS | |
| 4 | Peripheral swelling | FAERS: 2 | US FAERS | |
| 5 | Vomiting | FAERS: 2 | US FAERS | |
| 6 | Alopecia | FAERS: 1 | US FAERS | |
| 7 | Atrial Fibrillation | FAERS: 1 | US FAERS | |
| 8 | Back Pain | FAERS: 1 | US FAERS | |
| 9 | Blood count abnormal | FAERS: 1 | US FAERS | |
| 10 | Bone pain | FAERS: 1 | US FAERS | |
| 11 | Constipation | FAERS: 1 | US FAERS | |
| 12 | Disease Progression | FAERS: 1 | US FAERS | |
| 13 | Fatigue | FAERS: 1 | US FAERS | |
| 14 | Flushing | FAERS: 1 | US FAERS | |
| 15 | Malignant neoplasm progression | FAERS: 1 | US FAERS | |
| 16 | Product use in unapproved indication | FAERS: 1 | US FAERS | |
| 17 | Skin reaction | FAERS: 1 | US FAERS | |
| 18 | T-Cell Lymphoma | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120264
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.